Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

The study aims to find the best treatment for central serous chorioretinopathy by comparing various options.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Ashy dermatosis may be linked to atopy and thyroid disease and can be treated with topical steroids.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Minoxidil effectively lowers blood pressure and initially increases plasma renin activity without raising aldosterone levels.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

COVID-19 may harm male fertility and damage the reproductive system.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

A 6-group hair classification is more reliable for drug testing than an 8-group system.

Lipid-coated silica nanoparticles penetrate human skin more deeply than bare silica nanoparticles.